Discovery of New Novel Molecule Sparks Hope for Pain and Depression Treatment
Researchers from the Luxembourg Institute of Health (LIH) have developed a new molecule called LIH383. In a press release, they claim that this new novel molecule binds to and blocks specific opioid peptides in the brain, thus regulating the levels of opioid peptides in the entire central nervous system.
No comments:
Post a Comment